Skip to main content
SpringerLink
Log in

Pantoprazole is a highly effective option for gastric acid-related disorders

  • New Drugs and Therapeutic
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fitton A, Wiseman L. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996 Mar; 51(3): 460–82

    CAS  Google Scholar 

  2. Spencer CM, Faulds D. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. Drugs 1994; 48(3): 404–430

    CAS  Google Scholar 

  3. Wilde MI, McTavish D. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs 1994; 48(1): 91–132

    CAS  Google Scholar 

  4. Pantoprazole launched in France. Scrip 1996 Apr 2; (2116): 19

  5. Benet LZ, Zech K. Pharmacokinetics — a relevant factor for the choice of a drug? Aliment Pharmacol Ther 1994; 8 (Suppl.l): 25–32

    PubMed  Google Scholar 

  6. British National Formulary No. 31. London: The Pharmaceutical Press, 1996 Mar: 37–40, 556

  7. Kromer W. Similarities and differences in the properties of substituted benzimidazoles: a comparison between pantoprazole and related compounds. Digestion 1995; 56: 443–454

    Article  PubMed  CAS  Google Scholar 

  8. Hotz J, Plein K, Schönekäs H. Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. Scand J Gastroenterol 1995 Feb;30: 111–5

    Article  PubMed  CAS  Google Scholar 

  9. Witzel L, Gütz H, Hüttermann W, et al. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. Aliment Pharmacol Ther 1995 Feb; 9: 19–24

    Article  PubMed  CAS  Google Scholar 

  10. Hahn EG, Dammann HG, Adler G, et al. Pantoprazole provides faster healing and pain relief than famotidine in acute duodenal ulcer disease. Gastroenterology. In press.

  11. Koop H, Schepp W, Dammann HG, et al. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis: results of a German multicenter study. J Clin Gastroenterol 1995 Apr; 20: 192–5

    Article  PubMed  CAS  Google Scholar 

  12. Dammann HG, Hahn EG, Adler G, et al. Pantoprazole is more effective than famotidine in acute gastro-esophageal reflux disease. Gastroenterology. In press.

  13. Brunner G, Harke U. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Aliment Pharmacol Ther 1994; 8 Suppl. 1: 59–64

    PubMed  Google Scholar 

  14. Bardhan KD, Cherian P, Polak JM, et al. Pantoprazole (PANTO) in aggressive or refractory acid-peptic disease. Gastroenterology. In press.

  15. Suerbaum S, Leying H, Klemm K, et al. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991 Feb; 10: 92–3

    Article  PubMed  CAS  Google Scholar 

  16. Scholten T, Adler G, Bosseckert H, et al. Clinical tolerability of pantoprazole compared to H2-antagonists: results of the German pantoprazole phase IV program. Gastroenterology. In press

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pantoprazole is a highly effective option for gastric acid-related disorders. Drugs Ther. Perspect 8, 1–5 (1996). https://doi.org/10.2165/00042310-199608040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199608040-00001

Search

Navigation